Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia

Charles Gawad, Francois Pepin, Victoria E. H. Carlton, Mark Klinger, Aaron C. Logan, David B. Miklos, Malek Faham, Gary Dahl, Norman Lacayo

Blood (2012) 120 (22): 4407–4417.

https://doi.org/10.1182/blood-2012-05-429811

Published: 2012

Includes: Supplemental data

Journal Articles

The incidence and clinical significance of nucleophosmin mutations in childhood AML

Patrick Brown, Emily McIntyre, Rachel Rau, Soheil Meshinchi, Norman Lacayo, Gary Dahl, Todd A. Alonzo, Myron Chang, Robert J. Arceci, Donald Small

Blood (2007) 110 (3): 979–985.

https://doi.org/10.1182/blood-2007-02-076604

Published: 2007

Journal Articles

Incidence and Clinical Significance of Nucleophosmin Mutations in Childhood AML: A Childrens Oncology Group Study.

Patrick Brown, MD, Emily McIntyre, Rachel Rau, MD, Todd A. Alonzo, PhD, Robert Gerbing, MA, Soheil Meshinchi, MD PhD, Norman Lacayo, MD, Myron Chang, PhD, Robert Arceci, MD PhD, Donald Small, MD PhD

Blood (2006) 108 (11): 221.

https://doi.org/10.1182/blood.V108.11.221.221

Published: 2006

Journal Articles

Gene Expression Profiling and FLT3 Status Correlate with Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Norman Lacayo, MD, Soheil Meshinchi, MD, Susana Raimondi, PhD, Chitra Saraiya, MS, Maureen O’Brien, MD, Ronald Yu, PhD, Dejan Juric, MD, Myron Chang, PhD, Cheryl Willman, MD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Branimir Sikic, MD, Howard Weinstein, MD, Gary Van Houten Dahl, MD

Blood (2005) 106 (11): 2372.

https://doi.org/10.1182/blood.V106.11.2372.2372

Published: 2005

Journal Articles

Improved Remission Induction Rate of Childhood AML: Preliminary Results of the AML02 Trial.

Jeffrey Rubnitz, MD, PhD, Bassem Razzouk, MD, Paul Bowman, MD, Gary Dahl, MD, Norman Lacayo, MD, Jeffrey Taub, MD, Yaddanapudi Ravindranath, MD, Soheil Meshinchi, MD, PhD, Gladstone Airewele, MD, Shelly Lensing, MS, Stanley Pounds, PhD, Raul Ribeiro, MD, Ching-Hon Pui, MD, Elaine Coustan-Smith, MS, Dario Campana, MD

Blood (2005) 106 (11): 275.

https://doi.org/10.1182/blood.V106.11.275.275

Published: 2005

NARROW

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia

The incidence and clinical significance of nucleophosmin mutations in childhood AML

Incidence and Clinical Significance of Nucleophosmin Mutations in Childhood AML: A Childrens Oncology Group Study.

Gene Expression Profiling and FLT3 Status Correlate with Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Improved Remission Induction Rate of Childhood AML: Preliminary Results of the AML02 Trial.

Email alerts

ASH Publications

American Society of Hematology

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia

The incidence and clinical significance of nucleophosmin mutations in childhood AML

Incidence and Clinical Significance of Nucleophosmin Mutations in Childhood AML: A Childrens Oncology Group Study.

Gene Expression Profiling and FLT3 Status Correlate with Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Improved Remission Induction Rate of Childhood AML: Preliminary Results of the AML02 Trial.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only